CINECA IRIS Institutional Research Information System

MARCHIO', Caterina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.638
EU - Europa 4.351
AS - Asia 2.743
SA - Sud America 77
AF - Africa 65
OC - Oceania 44
Continente sconosciuto - Info sul continente non disponibili 5
Totale 14.923
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.498
IT - Italia 1.504
CN - Cina 1.331
IE - Irlanda 610
SG - Singapore 482
SE - Svezia 407
FR - Francia 311
DE - Germania 284
AT - Austria 210
FI - Finlandia 208
UA - Ucraina 179
VN - Vietnam 178
GB - Regno Unito 162
JP - Giappone 160
IN - India 148
PL - Polonia 126
KR - Corea 122
ID - Indonesia 118
CA - Canada 116
HK - Hong Kong 87
NL - Olanda 65
ES - Italia 48
BR - Brasile 40
AU - Australia 37
RU - Federazione Russa 35
BE - Belgio 34
CH - Svizzera 31
TR - Turchia 29
SN - Senegal 27
TW - Taiwan 26
RO - Romania 25
PT - Portogallo 23
MX - Messico 19
NO - Norvegia 16
CL - Cile 15
GR - Grecia 15
IR - Iran 15
DK - Danimarca 10
CZ - Repubblica Ceca 9
HU - Ungheria 9
NG - Nigeria 9
EG - Egitto 7
NZ - Nuova Zelanda 7
UZ - Uzbekistan 7
RS - Serbia 6
ZA - Sudafrica 6
AR - Argentina 5
PE - Perù 5
PK - Pakistan 5
QA - Qatar 5
TH - Thailandia 5
BA - Bosnia-Erzegovina 4
CO - Colombia 4
EU - Europa 4
IQ - Iraq 4
MY - Malesia 4
PH - Filippine 4
SA - Arabia Saudita 4
VE - Venezuela 4
AL - Albania 3
SI - Slovenia 3
TG - Togo 3
AE - Emirati Arabi Uniti 2
BM - Bermuda 2
BW - Botswana 2
CI - Costa d'Avorio 2
IS - Islanda 2
JO - Giordania 2
KE - Kenya 2
LB - Libano 2
LI - Liechtenstein 2
LT - Lituania 2
PY - Paraguay 2
SD - Sudan 2
SK - Slovacchia (Repubblica Slovacca) 2
A1 - Anonimo 1
BG - Bulgaria 1
BO - Bolivia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
EC - Ecuador 1
EE - Estonia 1
GE - Georgia 1
HR - Croazia 1
IL - Israele 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
PS - Palestinian Territory 1
SC - Seychelles 1
SV - El Salvador 1
TN - Tunisia 1
TZ - Tanzania 1
ZW - Zimbabwe 1
Totale 14.923
Salva come PNG Salva come JPEG
Città #
Fairfield 725
Chandler 693
Dublin 604
Beijing 532
Houston 478
Ann Arbor 414
Ashburn 409
Torino 397
Woodbridge 372
Singapore 366
Wilmington 268
Seattle 251
Cambridge 208
Vienna 197
Pisa 191
Villeurbanne 171
Columbus 168
Medford 160
Princeton 160
Jacksonville 158
Nyköping 158
Redwood City 147
Dearborn 142
Turin 128
New York 120
Warsaw 118
Jakarta 113
Santa Clara 106
Dong Ket 95
Nanjing 81
Shanghai 78
Guangzhou 74
Milan 73
Pune 62
Hangzhou 61
San Diego 57
Boston 56
Toronto 44
Boardman 43
Fremont 39
Rome 38
Tokyo 35
Helsinki 34
Hong Kong 30
Hefei 29
London 29
Norwalk 28
Chengdu 27
Ottawa 26
Phoenix 26
Falls Church 24
Paris 23
Washington 23
Chicago 21
Wuhan 21
Silver Spring 18
Jinan 17
Los Angeles 17
Tianjin 17
Upper Marlboro 17
Brussels 15
Fuzhou 15
Moncalieri 15
Taipei 15
Central District 14
Changsha 14
Hebei 14
Munich 14
Pittsburgh 14
Chongqing 13
Fosses 13
Gainesville 13
Genoa 13
Kunming 13
Seoul 13
Verona 13
Zhengzhou 13
Carrara 12
Lexington 12
Madrid 12
Mountain View 12
Shenyang 11
Zola Predosa 11
Berlin 10
Bethesda 10
Bologna 10
Nagoya 10
Redmond 10
San Jose 10
Xian 10
Amsterdam 9
Frankfurt am Main 9
Ningbo 9
Padova 9
San Francisco 9
Santiago 9
Sydney 9
São Paulo 9
Abuja 8
Auburn Hills 8
Totale 9.679
Salva come PNG Salva come JPEG
Nome #
Hotspot activating PRKD1 somatic mutations in polymorphous low-grade adenocarcinomas of the salivary glands 626
BCAM and LAMA5 Mediate the Recognition between Tumor Cells and the Endothelium in the Metastatic Spreading of KRAS Mutant Colorectal Cancer 331
Enhanced cytotoxic effect of camptothecin nanosponges in anaplastic thyroid cancer cells in vitro and in vivo on orthotopic xenograft tumors 326
Molecular evidence in support of the neoplastic and precursor nature of microglandular adenosis. 262
Acid-free glyoxal as a substitute of formalin for structural and molecular preservation in tissue samples 261
Personalized therapeutic strategies in HER2-driven gastric cancer 245
Integrative molecular and functional profiling of ERBB2-amplified breast cancers identifies new genetic dependencies. 234
SF3B1mutations constitute a novel therapeutic target in breast cancer 228
Comprehensive clinical and molecular analyses of neuroendocrine carcinomas of the breast 228
A comprehensive PDX gastric cancer collection captures cancer cell intrinsic transcriptional MSI traits 221
Characterization of the genomic features and expressed fusion genes in micropapillary carcinomas of the breast 213
High rate of PIK3CA mutations but no TP53 mutations in low-grade adenosquamous carcinoma of the breast 195
High-throughput molecular analysis from leftover of fine needle aspiration cytology of mammographically detected breast cancer. 193
Distinctive pathological and clinical features of lung carcinoids with high proliferation index 186
Awareness of mutational artefacts in suboptimal DNA samples: possible risk for therapeutic choices 184
The expression of growth hormone releasing hormone (GHRH) and its receptors in breast carcinomas with apocrine differentiation - further evidence of the presence of a GHRH pathway in these tumors 179
Evolving concepts in HER2 evaluation in breast cancer: Heterogeneity, HER2-low carcinomas and beyond 178
miR-221/222 control luminal breast cancer tumor progression by regulating different targets 177
Differences and homologies of chromosomal alterations within and between breast cancer cell lines: a clustering analysis 170
Critical roles of specimen type and temperature before and during fixation in the detection of phosphoproteins in breast cancer tissues 169
Effect of low doses of estradiol and tamoxifen on breast cancer cell karyotypes 169
HER2 in Breast Cancer 168
Genetic analysis of microglandular adenosis and acinic cell carcinomas of the breast provides evidence for the existence of a low-grade triple-negative breast neoplasia family 163
THE EXPRESSION OF LINE1-MET CHIMERIC TRANSCRIPT IDENTIFIES A SUBGROUP OF AGGRESSIVE BREAST CANCERS 159
Thymidylate synthase maintains the de-differentiated state of triple negative breast cancers 159
Spontaneous and pronase-induced HER2 truncation increases the trastuzumab binding capacity of breast cancer tissues and cell lines. 157
Pathological non-response to chemotherapy in a neoadjuvant setting of breast cancer: an inter-institutional study 150
A collection of primary tissue cultures of tumors from vacuum packed and cooled surgical specimens: a feasibility study 148
Revisiting the technical validation of tumour biomarker assays: how to open a Pandora's box 146
Current Challenges for HER2 Testing in Diagnostic Pathology: State of the Art and Controversial Issues 146
Pleomorphism of the Nuclear Envelope in breast cancer: a new approach to an old problem 142
Unraveling the chromosome 17 patterns of FISH in interphase nuclei: an in-depth analysis of the HER2 amplicon and chromosome 17 centromere by karyotyping, FISH and M-FISH in breast cancer cells. 142
The impact of malignant nipple discharge cytology (NDc) in surgical management of breast cancer patients 142
Classification of pulmonary neuroendocrine tumors: New insights 142
Mitotic Spindle Assembly and Genomic Stability in Breast Cancer Require PI3K-C2α Scaffolding Function 141
The perfect pathology report after neoadjuvant therapy 140
The Dilemma of HER2 Double-equivocal Breast Carcinomas: Genomic Profiling and Implications for Treatment 139
“To Be or Not to Be in a Good Shape”: Diagnostic and Clinical Value of Nuclear Shape Irregularities in Thyroid and Breast Cancer 133
Micropapillary ductal carcinoma in situ of the breast: an inter-institutional study 132
Triple-negative breast cancer: the importance of molecular and histologic subtyping, and recognition of low-grade variants 129
Tissue arrays as fiducial markers for section alignment in 3-D reconstruction technology 128
PAX8–GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid 128
Extreme assay sensitivity in molecular diagnostics further unveils intratumour heterogeneity in metastatic colorectal cancer as well as artifactual low-frequency mutations in the KRAS gene 127
Search for Neuro-Endocrine Markers (Chromogranin A, Synaptophysin and VGF) in Breast Cancers. An integrated Approach Using Immunohistochemistry and Gene Expression Profiling 124
CUTseq is a versatile method for preparing multiplexed DNA sequencing libraries from low-input samples 116
Assessment of a High Sensitivity Method for Identification of IDH1 R132x Mutations in Tumors and Plasma of Intrahepatic Cholangiocarcinoma Patients 112
The repertoire of somatic genetic alterations of acinic cell carcinomas of the breast: an exploratory, hypothesis-generating study 111
Quantification of HER2 and estrogen receptor heterogeneity in breast cancer by single-molecule RNA fluorescence in situ hybridization 109
The Multifaceted Nature of Tumor Microenvironment in Breast Carcinomas 106
Small-cell carcinoma of the breast with squamous differentiation 102
Rediscovering secondary tumors of the prostate in the molecular era 102
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression 100
CXCL12 expression is a bona fide predictor of recurrence in lung neuroendocrine tumours; a multicentric study with emphasis on atypical carcinoids - a short report 99
Pathology and Molecular Pathology of Breast Cancer 97
Reccomendations for using of molecular assays on liquid biopsy: The first document provided by intersociety Group AIOM, SIF, SIAPEC-IAP, SIBioC 97
Identification of TENM4 as a novel cancer stem cell-associated molecule and potential target in triple negative breast cancer 95
Cold Formalin Fixation Guarantees DNA Integrity in Formalin Fixed Paraffin Embedded Tissues: Premises for a Better Quality of Diagnostic and Experimental Pathology With a Specific Impact on Breast Cancer 93
ESR1 mutations in metastatic lobular breast cancer patients 92
Next-Generation Sequencing in Clinical Practice: Is It a Cost-Saving Alternative to a Single-Gene Testing Approach? 92
RollFISH achieves robust quantification of single-molecule RNA biomarkers in paraffin-embedded tumor tissue samples 91
The genetic landscape of breast carcinomas with neuroendocrine differentiation 90
Caveolin 1 expression favors tumor growth and is associated with poor survival in primary lung adenocarcinomas 88
Predictive Diagnostic Pathology in the Target Therapy Era in Breast Cancer 87
Monosomy of chromosome 17 in breast cancer during interpretation of HER2 gene amplification 87
Traditional urinary cytology and tyrosinase RT-PCR in metastatic melanoma patients: correlation with clinical status 85
Patients with advanced stage breast carcinoma immunoreactive to biotinylated Herceptin are most likely to benefit from trastuzumab-based therapy: an hypothesis-generating study 85
Pursuit of Gene Fusions in Daily Practice: Evidence from Real-World Data in Wild-Type and Microsatellite Instable Patients 84
Breast carcinomas with low amplified/equivocal HER2 by Ish: Potential supporting role of multiplex ligation-dependent probe amplification 83
Breast cancer precursors revisited: molecular features and progression pathways. 79
Massively parallel sequencing analysis of synchronous fibroepithelial lesions supports the concept of progression from fibroadenoma to phyllodes tumor 77
Genetic analysis of uterine adenosarcomas and phyllodes tumors of the breast 74
CD44 is overexpressed in basal-like breast cancers but is not a driver of 11p13 amplification. 73
Gene Status in HER2 Equivocal Breast Carcinomas: Impact of Distinct Recommendations and Contribution of a Polymerase Chain Reaction-Based Method. 73
Neoplastic cell percentage estimation in tissue samples for molecular oncology: recommendations from a modified Delphi study 72
Reoperation rate after breast conserving surgery as quality indicator in breast cancer treatment: A reappraisal 72
PIKing the type and pattern of PI3K pathway mutations in endometrioid endometrial carcinomas 71
Routine assessment of prognostic factors in breast cancer using a multicore tissue microarray procedure 71
Optimized EGFR blockade strategies in EGFR addicted gastroesophageal adenocarcinomas 71
Immunohistochemical and molecular profiling of histologically defined apocrine carcinomas of the breast 70
Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes 70
RNASeq analysis reveals biological processes governing the clinical behaviour of endometrioid and serous endometrial cancers 70
Synthetic lethality screening highlights colorectal cancer vulnerability to concomitant blockade of nedd8 and egfr pathways 69
The role of molecular analysis in breast cancer. 68
Triple negative breast cancer: molecular profiling and prognostic impact in adjuvant anthracycline-treated patients. 67
Adenoid cystic carcinomas of the breast and salivary glands (or 'The strange case of Dr Jekyll and Mr Hyde' of exocrine gland carcinomas). 67
Breast Cancer Heterogeneity: Roles in Tumorigenesis and Therapeutic Implications 67
Changes in breast cancer biomarkers in the IGF1R/PI3K pathway in recurrent breast cancer after tamoxifen treatment. 66
Circulating tumor DNA to guide rechallenge with panitumumab in metastatic colorectal cancer: the phase 2 CHRONOS trial 65
Well-differentiated neuroendocrine tumour of the breast showing peculiar endovascular spread. 65
Chemotherapy with or without trastuzumab. 65
Inclusion of platinum agents in neoadjuvant chemotherapy regimens for triple-negative breast cancer patients: Development of GRADE (grades of recommendation, assessment, development and evaluation) recommendation by the Italian association of medical oncology (AIOM) 65
Loss of HER2 and decreased T-DM1 efficacy in HER2 positive advanced breast cancer treated with dual HER2 blockade: the SePHER Study 65
Does chromosome 17 centromere copy number predict polysomy in breast cancer? A fluorescence in situ hybridization and microarray-based CGH analysis 64
Tiling path genomic profiling of grade 3 invasive ductal breast cancers. 64
AXL Controls Directed Migration of Mesenchymal Triple-Negative Breast Cancer Cells 63
Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies 63
The ENDOPREDICT® molecular test for breast cancer prognosis: clinical-pathological correlations and therapeutic implications on a selected cohort of patients 62
Loss of 16q in high grade breast cancer is associated with estrogen receptor status: Evidence for progression in tumors with a luminal phenotype? 61
Genetic and pharmacological modulation of DNA mismatch repair heterogeneous tumors promotes immune surveillance 60
Genetic analysis of a morphologically heterogeneous ovarian endometrioid carcinoma 60
Totale 12.732
Salva come PNG Salva come JPEG
Categoria #
all - tutte 46.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 46.372
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.864 0 0 0 0 184 388 272 235 323 182 154 126
2020/20212.001 106 135 142 131 144 164 205 108 195 220 151 300
2021/20222.126 102 124 156 209 129 99 133 148 86 170 399 371
2022/20232.651 272 177 75 198 273 645 240 175 282 76 139 99
2023/20241.497 161 190 75 85 104 224 62 90 23 97 166 220
2024/20251.185 98 219 197 331 340 0 0 0 0 0 0 0
Totale 15.444